US Patent Issued to Bayer on Aug. 25 for "Anti-A2AP antibodies and uses thereof" (German, Swiss Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,932, issued on Aug. 25, was assigned to Bayer AG (Leverkusen, Germany).

"Anti-A2AP antibodies and uses thereof" was invented by Stefan Heitmeier (Wulfrath, Germany), Julia Glunz (Essen, Germany), Melanie Fischer (Riedstadt, Germany), Cindy Schulenburg (Zurich, Switzerland), Hannah Jorissen (Heiligenhaus, Germany), Christoph Thiel (Cologne, Germany), Andreas Wilmen (Cologne, Germany) and Ernst Weber (Langenfeld, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an isolated antibody or antigen-binding fragment thereof that binds to human A2AP. The isolated antibody or antigen-binding fragment according to the pres...